Literature DB >> 12421633

Multidrug resistance in the protozoan parasite Entamoeba histolytica.

E Orozco1, C López, C Gómez, D G Pérez, L Marchat, C Bañuelos, D M Delgadillo.   

Abstract

In this review we discuss the mechanisms and molecules involved in the multidrug resistance (MDR) of the protozoan parasite Entamoeba histolytica. Drug resistant mutants exhibited the main characteristics presented by the MDR mammalian cells. They showed cross-resistance to several unrelated drugs that is reverted by calcium channel blockers. MDR phenotype in E. histolytica is regulated at a transcriptional level by the EhPgp1 gene, which is constitutively expressed and by the EhPgp5 gene, whose expression is induced in the presence of the drug. Transcription factors participate in the expression regulation of these genes. After over transcription, the EhPgp genes are amplified, cooperating to produce the MDR phenotype. Post-transcriptional mechanisms such as mRNA stability seem to be involved in this phenomenon. As for other mdr gene products, the EhPGP5 protein functions as a chloride current inductor or as a regulator of cellular regulatory volume decrease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421633     DOI: 10.1016/s1383-5769(02)00041-7

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  11 in total

1.  In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica.

Authors:  S Ranque; B Molet; D Christmann; E Candolfi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

Review 2.  The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

Authors:  Isabel Wong-Baeza; Marcela Alcántara-Hernández; Ismael Mancilla-Herrera; Itzmel Ramírez-Saldívar; Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Constantino López-Macías; Armando Isibasi
Journal:  J Biomed Biotechnol       Date:  2010-01-21

3.  MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide.

Authors:  Adriana Ángeles-Arvizu; Sergio Enriquez-Flores; Alma Jiménez-Gutiérrez; Armando Pérez-Rangel; Juan Pedro Luna-Arias; Araceli Castillo-Romero; José Manuel Hernández; Gloria León-Avila
Journal:  Acta Parasitol       Date:  2021-04-11       Impact factor: 1.440

4.  A proteomic and cellular analysis of uropods in the pathogen Entamoeba histolytica.

Authors:  Jacques Marquay Markiewicz; Sylvie Syan; Chung-Chau Hon; Christian Weber; Daniela Faust; Nancy Guillen
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

5.  Phenolic Acid Composition and Anti-Parasitic Effects of Four Peucedanum Species on Entamoeba histolytica Trophozoites.

Authors:  Serpil Degerli; Bektas Tepe
Journal:  Iran J Parasitol       Date:  2015 Jul-Sep       Impact factor: 1.012

Review 6.  Multidrug resistance: an emerging crisis.

Authors:  Jyoti Tanwar; Shrayanee Das; Zeeshan Fatima; Saif Hameed
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-07-16

7.  A Novel Heat Shock Element (HSE) in Entamoeba histolytica that Regulates the Transcriptional Activation of the EhPgp5 Gene in the Presence of Emetine Drug.

Authors:  Alma Nieto; David G Pérez Ishiwara; Esther Orozco; Virginia Sánchez Monroy; Consuelo Gómez García
Journal:  Front Cell Infect Microbiol       Date:  2017-11-29       Impact factor: 5.293

8.  Furanocoumarins from Ruta chalepensis with Amebicide Activity.

Authors:  Aldo Fabio Bazaldúa-Rodríguez; Ramiro Quintanilla-Licea; María Julia Verde-Star; Magda Elizabeth Hernández-García; Javier Vargas-Villarreal; Jesús Norberto Garza-González
Journal:  Molecules       Date:  2021-06-16       Impact factor: 4.411

9.  Synthesis of novel hybrid molecules from precursors with known antiparasitic activity.

Authors:  Haythem A Saadeh; Ibrahim M Mosleh; Mohammad S Mubarak
Journal:  Molecules       Date:  2009-04-09       Impact factor: 4.411

10.  Comparative Genomics Supports Sex and Meiosis in Diverse Amoebozoa.

Authors:  Paulo G Hofstatter; Matthew W Brown; Daniel J G Lahr
Journal:  Genome Biol Evol       Date:  2018-11-01       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.